Utility of FIB4-T as a Prognostic Factor for Hepatocellular Carcinoma.
Kariyama K, Nouso K, Toyoda H, Tada T, Hiraoka A, Tsuji K, Itobayashi E, Ishikawa T, Wakuta A, Oonishi A, Kumada T, Kudo M, Group OBOTRPEFHRS, Group H.
Kariyama K, et al. Among authors: toyoda h.
Cancers (Basel). 2019 Feb 10;11(2):203. doi: 10.3390/cancers11020203.
Cancers (Basel). 2019.
PMID: 30744175
Free PMC article.